US FDA approves GSK's combo meningococcal vaccine
The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
The Lancet15d
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant
2 vaccination. All individuals received two to three doses of the ancestral mRNA vaccine, followed by either none or one dose of the bivalent vaccine or the XBB.1.5 monovalent vaccine. We used an in ...
The Lancet15d
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant
aCenter for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA ...
Yahoo Finance16d
GSK and University of Oxford partner for cancer vaccine research
In a separate development, the European Medicines Agency (EMA) has accepted GSK’s application for a prefilled syringe presentation of recombinant zoster vaccine, Shingrix, for review ...
Mashable17d
'Moana 2' review: Almost as great as the original, except for one big thing
If she goes, she risks not coming back to her family or her beloved island. Here's where Moana 2 really shows us how far Moana has grown. With age and greater status in Motunui, she's become far ...
eLife17d
Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques
Following a two-week interval, a booster vaccination was administered via the subcutaneous route using 2×10 6 PFU of recombinant HSV-vector vaccines. The subsequent assessment of the immune response ...
eLife17d
Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques
Authors constructed a novel HSV-based therapeutic vaccine to cure SIV in a primate model ... the authors that no full mechanistic explanation can be given at this moment. (2) No toxicity data are ...
PharmiWeb18d
GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency
2,3,4 Over 25 million people in Europe have received GSK’s shingles vaccine since 2018 5 GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the ...
Pharmaceutical Technology18d
GSK and University of Oxford partner for cancer vaccine research
In a separate development, the European Medicines Agency (EMA) has accepted GSK’s application for a prefilled syringe presentation of recombinant zoster vaccine, Shingrix, for review, to prevent ...
Yahoo Finance18d
GSK and Oxford researchers to create cancer vaccine to stop disease developing
Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...
This is Local London18d
GSK and Oxford researchers to create cancer vaccine to stop disease developing
Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...